<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Unresponsive <z:hpo ids='HP_0001890'>autoimmune haemolytic anaemia</z:hpo> (AIHA) may require therapy with second-line drugs </plain></SENT>
<SENT sid="1" pm="."><plain>There is no consensus that any one of these agents is more effective than another </plain></SENT>
<SENT sid="2" pm="."><plain><z:chebi fb="0" ids="168396">Mycophenolate</z:chebi> mofetil (MMF) is an immunosuppressive drug proven to be effective in reducing renal allograft rejection as well as being used in <z:hpo ids='HP_0002960'>autoimmune diseases</z:hpo> including <z:hpo ids='HP_0002725'>systemic lupus erythematosus</z:hpo> (SLE) </plain></SENT>
<SENT sid="3" pm="."><plain>We describe its use in two patients who were treated with MMF for AIHA in the context of underlying SLE and <z:e sem="disease" ids="C0085278" disease_type="Disease or Syndrome" abbrv="">antiphospholipid syndrome</z:e> (APS) </plain></SENT>
<SENT sid="4" pm="."><plain>The patients showed a good response to treatment with MMF, suggesting a possible role in the treatment of AIHA </plain></SENT>
</text></document>